Login or sign up
For business

Tarix Orphan

4.1ยท 11 reviews
Average ratingGreat
4.1/ 5

Based on 11 reviews

536%
436%
327%
20%
10%
Ask AI

Ask AI about Tarix Orphan

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Sanket Sheth
Reviews 1

I stumbled upon this organization and I'm amazed by the work they do. Tarix Orphan is making a positive impact on the lives of orphaned children. The website provides all the necessary details, making it easy to understand how one can contribute to their cause.

Rafael Garza
Reviews 1

I must say, Tarix Orphan is a wonderful company to work with. Their professionalism and dedication in helping the orphans are commendable. The website is user-friendly and provides all the necessary information about their services. I highly recommend Tarix Orphan!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Tarix Orphan

Tarix Orphan is a private biopharmaceutical company headquartered in Cambridge, MA. Tarix Orphan is developing TXA127 for rare neuromuscular and connective tissue diseases. TXA127 is a pharmaceutical formulation of the naturally occurring peptide, Angiotensin (1-7). TXA127 has been effective in animal models of Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD), congenital muscular dystrophy MDC1A, Marfan syndrome, and Dystrophic Epidermolysis Bullosa (DEB). Tarix Orphan has broad IP protection for TXA127 and Orphan Drug Designations (ODDs) have been granted for DMD LGMD and DEB in the U.S.,